PreciPoint GmbH successfully certified according to ISO 13485

Seal of quality for medical technology: after successful auditing by TÜV Süd, PreciPoint GmbH, which specializes in digitization solutions in the field of microscopy, has been officially certified according to ISO 13485:2016 since June 2022. This seal certifies that the company’s all relevant business processes meet the regulatory requirements as a developer and manufacturer for medical devices.   

PreciPoint manufactures solutions for the digitization of microscopy and laboratory processes for applications in medicine, research and education. The company already collaborates with many prestigious pathologies in Germany in the development of its products. In these projects, promising approaches in the treatment of numerous cancers are being advanced, while at the same time the devices are being developed that make these research results visible and at the same time simplify laboratory processes. PreciPoint’s devices must be easy and fast to operate, while at the same time meeting the highest scientific standards.   

In 2022, PreciPoint will present the iO:M8 ROSE, a distinctive solution for the digitization of intra-operative examinations in cancer surgery. These examinations, in which pathologists determine during surgery whether sufficient material has been removed from the patient’s body and whether the edges of the operated site are free of cancer cells, are traditionally performed in a time- and place-bound manner using classical light microscopy.   

PreciPoint’s microscopy solutions enable digital ways of working, allowing significant cost savings and faster data exchange among specialists. "In view of the ever-increasing shortage of pathologic specialists and the simultaneous rise in cancer cases in Germany, Europe and worldwide, solutions like ours are essential," explains Dominik Gerber, who heads the company together with Nicolas Weiss. With the ISO 13485:2016 certification, another requirement has been met to make PreciPoint’s products accessible to a wider range of customers in the medical field. "Together with our employees, we have reached an important milestone of which we can be very proud," says Nicolas Weiss.   

Über die PreciPoint GmbH

PreciPoint specializes in the development, production, and marketing of innovative digitization solutions and photonics systems in the field of microscopy. Already offered on the market are the microscopy solutions M8, O8 as well as FRITZ. All devices are fully motorized transmitted light microscopes users control via software. The solutions work digitally, do not require an eyepiece, and produce high-resolution images of the samples, which can easily be stored digitally. The microscopes impress with easy and intuitive user interfaces. Furthermore, the devices can be equipped with a remote function so that they can also be accessed from any location. In addition to hardware products, the company offers versatile software applications with which the images can be visualized, processed, and analyzed. The virtual microscopy platform PreciCloud enables new working models between experts, researchers, and students. PreciPoint’s customer base already includes many well-known users worldwide. Based in Freising, Germany, PreciPoint is an ISO 13485 certified medical device company and one of the Top Startups in Germany. The company has won various awards, including 3rd place as Top Innovator 2022, in which PreciPoint prevailed as a particularly innovative company against almost 450 companies, and the award as Top Startup Employer in the healthcare sector.

Firmenkontakt und Herausgeber der Meldung:

PreciPoint GmbH
Parkring 6
85748 Garching
Telefon: +49 (0) 89 2152 5320
Telefax: +49 (89) 8120569
http://precipoint.de

Ansprechpartner:
Nicolas Weiss
CEO
E-Mail: nicolas.weiss@precipoint.de
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel